IM Cannabis Corp. current report, Q2 FY2022

IM Cannabis Corp. Form 6-K Summary

Business Context and Reporting Period

IM Cannabis Corp., an Israeli foreign private issuer, filed Form 6-K on April 11, 2022, covering the month of April 2022. The company files annual reports on Form 40-F.

Financial and Operating Metrics

This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not describe material changes versus a prior comparable period.

Outlook, Risks, and Unusual Items

The filing contains no guidance, outlook, management commentary, risk disclosures, contingencies, or unusual financial items. It includes Exhibit 99.1, identified as a Form 11 notice of proposed stock option grant or amendment dated April 11, 2022; the substantive terms of that exhibit are not included in the provided filing text.

Key Facts to Verify

  • Review Exhibit 99.1 for the number of options, exercise price, vesting terms, expiration date, and recipients.
  • Verify whether the proposed grant or amendment affects dilution, share-based compensation, or insider ownership.
  • Consult the company’s applicable financial filings for financial performance, liquidity, debt, and outlook information.